The Coca-Cola Co (NYSE:KO) Shares Purchased by Cullinan Associates Inc.

Share on StockTwits

Cullinan Associates Inc. increased its position in The Coca-Cola Co (NYSE:KO) by 0.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,268,949 shares of the company’s stock after purchasing an additional 7,607 shares during the quarter. The Coca-Cola makes up 4.7% of Cullinan Associates Inc.’s portfolio, making the stock its 2nd biggest position. Cullinan Associates Inc.’s holdings in The Coca-Cola were worth $70,236,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Corient Capital Partners LLC grew its position in shares of The Coca-Cola by 10.0% during the 3rd quarter. Corient Capital Partners LLC now owns 131,791 shares of the company’s stock worth $7,175,000 after buying an additional 11,966 shares during the period. Bfsg LLC grew its position in shares of The Coca-Cola by 4.2% during the 3rd quarter. Bfsg LLC now owns 8,153 shares of the company’s stock worth $444,000 after buying an additional 328 shares during the period. River & Mercantile Asset Management LLP grew its position in shares of The Coca-Cola by 7.2% during the 2nd quarter. River & Mercantile Asset Management LLP now owns 213,007 shares of the company’s stock worth $10,843,000 after buying an additional 14,330 shares during the period. Whittier Trust Co. grew its position in shares of The Coca-Cola by 1.5% in the 3rd quarter. Whittier Trust Co. now owns 253,185 shares of the company’s stock valued at $13,781,000 after purchasing an additional 3,680 shares during the period. Finally, Boston Advisors LLC grew its position in shares of The Coca-Cola by 28.4% in the 3rd quarter. Boston Advisors LLC now owns 144,782 shares of the company’s stock valued at $7,882,000 after purchasing an additional 31,997 shares during the period. Institutional investors own 67.54% of the company’s stock.

Several brokerages recently issued reports on KO. Guggenheim set a $59.00 price objective on The Coca-Cola and gave the company a “buy” rating in a research report on Friday, October 18th. UBS Group upgraded The Coca-Cola from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $55.00 to $63.00 in a research report on Wednesday, October 23rd. Evercore ISI reiterated a “buy” rating and issued a $60.00 price objective on shares of The Coca-Cola in a research report on Sunday, November 17th. Wells Fargo & Co set a $60.00 price objective on The Coca-Cola and gave the company a “buy” rating in a research report on Monday, October 21st. Finally, Deutsche Bank boosted their price objective on The Coca-Cola from $60.00 to $61.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. Seven investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $57.05.

NYSE KO opened at $56.70 on Thursday. The stock has a market capitalization of $239.93 billion, a price-to-earnings ratio of 27.26, a PEG ratio of 3.81 and a beta of 0.42. The stock’s 50 day moving average price is $54.65 and its two-hundred day moving average price is $53.75. The company has a debt-to-equity ratio of 1.50, a quick ratio of 0.79 and a current ratio of 0.92. The Coca-Cola Co has a 52 week low of $44.42 and a 52 week high of $56.98.

The Coca-Cola (NYSE:KO) last released its earnings results on Friday, October 18th. The company reported $0.56 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.56. The firm had revenue of $9.51 billion for the quarter, compared to analysts’ expectations of $9.42 billion. The Coca-Cola had a return on equity of 45.21% and a net margin of 22.41%. The business’s quarterly revenue was up 8.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.57 EPS. On average, equities research analysts forecast that The Coca-Cola Co will post 2.1 EPS for the current year.

In other news, SVP Lisa Chang bought 500 shares of the business’s stock in a transaction on Thursday, October 24th. The shares were purchased at an average price of $54.55 per share, for a total transaction of $27,275.00. Following the purchase, the senior vice president now owns 5,948 shares of the company’s stock, valued at approximately $324,463.40. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Nancy Quan sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, January 13th. The shares were sold at an average price of $46.00, for a total value of $460,000.00. Following the completion of the sale, the senior vice president now owns 175,049 shares in the company, valued at approximately $8,052,254. The disclosure for this sale can be found here. Insiders sold a total of 167,678 shares of company stock worth $9,124,570 in the last 90 days. Company insiders own 1.33% of the company’s stock.

About The Coca-Cola

The Coca-Cola Company, a beverage company, manufactures and distributes various nonalcoholic beverages worldwide. The company provides sparkling soft drinks; water, enhanced water, and sports drinks; juice, dairy, and plant-based beverages; teas and coffees; and energy drinks. It also offers concentrates, syrups, beverage bases, source waters, and powders/minerals, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores.

See Also: How to Invest in an Index Fund

Want to see what other hedge funds are holding KO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Coca-Cola Co (NYSE:KO).

Institutional Ownership by Quarter for The Coca-Cola (NYSE:KO)

Receive News & Ratings for The Coca-Cola Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Coca-Cola and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.